Exchange: NASDAQ·Updated 06:15 AM EDT
INM logo

INM InMed Pharmaceuticals Inc

$1.40
$0.04
(2.94%)
Pre-Market
Prev Close $1.36
Reported EarningsMay 13
Mkt Cap$7.47M
Vol1,074.00

About INM

InMed Pharmaceuticals, Inc. is a pharmaceutical drug development company, which engages in developing small molecule drug candidates that are preferential signaling ligands of the endogenous CB1 and CB2 receptors as well as other receptor targets linked to human disease. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
51

Neutral Sentiment

How do you feel about INM?

Advertisement|Remove ads.